Literature DB >> 11553959

Healing response to the Clamshell device for closure of intracardiac defects in humans.

J Kreutzer1, C A Ryan, K Gauvreau, R Van Praagh, J M Anderson, K J Jenkins.   

Abstract

The healing response to intracardiac devices in humans is largely unknown. During regulatory trials using the Clamshell device in over 800 patients, attempts were made to perform histopathological evaluation of all explanted devices. We reviewed all those with complete histopathological examination (n = 12) from Fontan baffles (n = 4), ventricular septal defects (n = 2), and atrial septal defects (ASD; n = 6), explanted at 2.7 months to 3.6 years (median, 1.6 years), at autopsy (n = 1) or surgery (n = 11), performed for residual defects (n = 5), atrial masses (n = 3), or Fontan revision (n = 3). All but one were nearly (n = 3) or completely (n = 8) covered by pseudointima, composed of fibroelastic tissue, predominantly collagen, with focal foreign body reaction in contact with fabric, without acute inflammation or infection. Atrial masses of granulation tissue were present in three cases (ASD), opposite to protruding fractured arms. No associations were identified between coverage and closure status, position, arm fractures, or implant period. In conclusion, the healing response to transcatheter Clamshell implantation in humans is characterized by a relatively rapid development of a nonthrombotic pseudointima composed of fibroelastic tissue with minimal foreign body reaction. Cathet Cardiovasc Intervent 2001;54:101-111. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11553959     DOI: 10.1002/ccd.1248

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  11 in total

Review 1.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

2.  Cardiovascular implantable device infections.

Authors:  George M Viola; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

3.  Biocompatibility of septal defect closure devices.

Authors:  Matthias Sigler; Christian Jux
Journal:  Heart       Date:  2006-10-11       Impact factor: 5.994

Review 4.  Infective endocarditis in congenital heart disease.

Authors:  Walter Knirsch; David Nadal
Journal:  Eur J Pediatr       Date:  2011-07-20       Impact factor: 3.183

Review 5.  Role of animal models for percutaneous atrial septal defect closure.

Authors:  Zakaria Jalal; Pierre-Emmanuel Seguela; Alban-Elouen Baruteau; David Benoist; Olivier Bernus; Olivier Villemain; Younes Boudjemline; Xavier Iriart; Jean-Benoit Thambo
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Study of biodegradable occluder of atrial septal defect in a porcine model.

Authors:  Bo-Ning Li; Yu-Mei Xie; Zhao-Feng Xie; Xian-Miao Chen; Gui Zhang; De-Yuan Zhang; Xiang-Dong Liu; Zhi-Wei Zhang
Journal:  Catheter Cardiovasc Interv       Date:  2018-09-09       Impact factor: 2.692

7.  Angioscopic Evaluation of Atrial Septal Defect Closure Device Neo-Endothelialization.

Authors:  Yasuhiro Tanabe; Tomomi Suzuki; Shingo Kuwata; Masaki Izumo; Hiromasa Kawaguchi; Shun Ogoda; Nozomi Kotoku; Yukio Sato; Haruka Nishikawa; Toshiki Kaihara; Masashi Koga; Takanobu Mitarai; Kazuaki Okuyama; Ryo Kamijima; Yuki Ishibashi; Kihei Yoneyama; Takumi Higuma; Tomoo Harada; Yoshihiro J Akashi
Journal:  J Am Heart Assoc       Date:  2021-09-17       Impact factor: 5.501

8.  Transvenous closure of patent foramen ovale: preliminary results with a new self-expanding nitinol wire mesh in a Swine model.

Authors:  F Krizanic; M Sigler; H R Figulla
Journal:  Cardiol Res Pract       Date:  2009-09-09       Impact factor: 1.866

9.  Transcatheter interruption of large residual flow after device closure of "Type A" patent ductus arteriosus.

Authors:  Anuradha Sridhar; Raghavan Subramanyan; Premsekar Rajasekar
Journal:  Ann Pediatr Cardiol       Date:  2012-07

10.  A comparison of the in vivo neoendothelialization and wound healing processes of three atrial septal defect occluders used during childhood in a nonrandomized prospective trial.

Authors:  Derya Aydın Şahin; Osman Başpınar; Ayşe Sülü; Tekin Karslıgil; Seval Kul
Journal:  Anatol J Cardiol       Date:  2017-07-25       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.